A detailed history of Bbr Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bbr Partners, LLC holds 1,659 shares of LLY stock, worth $1.48 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,659
Previous 2,488 33.32%
Holding current value
$1.48 Million
Previous $1.94 Million 22.38%
% of portfolio
0.12%
Previous 0.16%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $600,917 - $753,594
-829 Reduced 33.32%
1,659 $1.5 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $78,170 - $104,580
-132 Reduced 5.04%
2,488 $1.94 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $278,350 - $328,138
-530 Reduced 16.83%
2,620 $1.53 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $406,009 - $559,746
934 Added 42.15%
3,150 $1.69 Million
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $48,402 - $64,719
138 Added 6.64%
2,216 $1.04 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $207,811 - $244,064
-669 Reduced 24.35%
2,078 $713,000
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $76,207 - $88,796
237 Added 9.44%
2,747 $1 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $88,647 - $101,023
-299 Reduced 10.64%
2,510 $812,000
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $7,804 - $9,163
28 Added 1.01%
2,809 $911,000
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $234,690 - $291,660
1,000 Added 56.15%
2,781 $796,000
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $16,638 - $20,648
-74 Reduced 3.99%
1,781 $492,000
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $18,171 - $22,362
-82 Reduced 4.23%
1,855 $429,000
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $20,221 - $26,156
-112 Reduced 5.47%
1,937 $445,000
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $164 - $212
-1 Reduced 0.05%
2,049 $383,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $9,784 - $12,947
75 Added 3.8%
2,050 $346,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $288,784 - $334,031
1,975 New
1,975 $292,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bbr Partners, LLC Portfolio

Follow Bbr Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.